Dr. Philip Owen Katz, MD

Dr. Katz practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Katz's NPI, 1124097340, was assigned on March 17, 2006. Dr. Katz graduated from Wake Forest School of Medicine in 1978. Dr. Katz's Pennsylvania license number on file is MD058206L.

Dr. Katz's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Katz's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Katz to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katz practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Katz's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Katz is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Katz's licenses on file in 6 states: Pennsylvania, Florida, New York, North Carolina, Maryland and New Jersey.

Dmand AI lists acid reflux, chronic indigestion, colonoscopy and upper GI endoscopy among the conditions Dr. Katz treats.

CMS data shows 446 Medicare services from Dr. Katz across 11 procedure codes in 2024, for 226 Medicare patients. Medicare paid $36,282 for them.

CMS counts 226 Medicare patients who saw Dr. Katz in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high cholesterol, and 63% have arthritis. 16% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Katz's median patient age at 67, with 57% women.

In 2024, Dr. Katz wrote 138 Medicare Part D claims for 59 patients. 91% of them were for generic drugs. CMS names the drug for 109 of them, across 4 drugs with 11 or more claims each, at $2,566 in total drug cost. In 2023, CMS named 84 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Katz for performance year 2024, reported through an alternative payment model (APM). Dr. Katz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Katz as offering telehealth. CMS counts 106 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Katz, more than 78% of the clinicians it reports for that procedure.

Dmand AI links 148 papers to Dr. Katz, published from 2009 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Gastroesophageal Reflux, Proton Pump Inhibitors and Manometry. Dr. Katz has published most often in Aliment Pharmacol Ther. Dr. Katz's most frequent co-authors are Felice H. Schnoll-Sussman, MD, Stuart Jon Spechler, MD and David A. Katzka, MD.

CMS Open Payments shows 67 general payments to Dr. Katz from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. Torax Medical, Inc. paid the most, $12,174.

Dmand AI lists 1 award for Dr. Katz.

Dr. Katz graduated from Wake Forest School of Medicine in 1978. Dr. Katz is a member of AOA.

Dr. Katz is in network with 16 carriers, including United Healthcare, Excellus BlueCross BlueShield and HCSC. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.